Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries. Review uri icon

Overview

abstract

  • Systemic lupus erythematosus (SLE) is a serious chronic autoimmune disease with substantial morbidity and mortality. Although improved diagnostics and therapeutics have contributed to declining mortality rates, important disparities exist in SLE survival rates by race, ethnicity, gender, age, country, and social disadvantage. This review highlights the burden of SLE and lupus nephritis among Medicaid beneficiaries, outlines barriers in access to high-quality SLE care and medication adherence in the Medicaid SLE population, and summarizes disparities in adverse outcomes among SLE patients enrolled in Medicaid.

publication date

  • October 29, 2020

Research

keywords

  • Lupus Erythematosus, Systemic
  • Lupus Nephritis

Identity

PubMed Central ID

  • PMC8171807

Scopus Document Identifier

  • 85094813544

Digital Object Identifier (DOI)

  • 10.1016/j.rdc.2020.09.004

PubMed ID

  • 34042053

Additional Document Info

volume

  • 47

issue

  • 1